Item 8.01 Other Events.

On January 28, 2021, Organicell issued a press release in which it announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its lead product, Zofin™, in the treatment of patients diagnosed with chronic obstructive pulmonary disease (COPD).

A copy of the Company's press release dated January 28, 2021 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits





 (d) Exhibits




Exhibit No   Description

   99.1        Press Release, dated January 28, 2021




                                       1

© Edgar Online, source Glimpses